Work

Expanding the Role of Prescription Drug Monitoring Programs

Year: 2026

Type: article

Abstract: This Viewpoint proposes an expansion of state-run prescription-drug monitoring programs to meet the need for broader pharmacovigilance given the shift to alternative payment methods that bypass traditional insurance claims.

Source: JAMA Health Forum

DOI: 10.1001/jamahealthforum.2026.0273

Author: Ashlee N. Mattingly

Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research, University of Utah

Language: English

Topic: Opioid Use Disorder Treatment

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $5,000

OpenAlex ID: W7154720671

FWCI: 19.17

Cites: 7

Cited by: 3

Related to: